1. Market Research
  2. > All Companies
  3. > Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bayer AG (Bayer) carries out the development, production and commercialization of healthcare products, nutritional supplements and specialty materials. The product portfolio of the company comprises animal health products, consumer care products, medical care products, pharmaceuticals, fungicides, insecticides, herbicides, polyurethanes, polycarbonates, coatings, adhesives and specialties. It caters to pharmaceutical, agricultural and polymer industries. Bayer also operates radiology business unit that markets contrast-enhanced diagnostic imaging equipment jointly with the necessary contrast agents. It operates through a network of subsidiaries in Asia-Pacific, Europe, the US, and other markets such as Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 23, 2016: Dr. Michael Preuss to be new head of Communications at Bayer
Feb 25, 2016: Another record year for Bayer
Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG
Feb 09, 2016: Bayer Continues to Grow its Open Innovation Activities
Dec 17, 2015: American Association for Cancer Research and Bayer Form Partnership on Grant Opportunities in Cancer Research

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Bayer AG - Key Facts 6
Bayer AG - Key Employees 7
Bayer AG - Key Employee Biographies 10
Bayer AG - Major Products and Services 11
Bayer AG - Pharmaceutical Pipeline Products Data 14
Bayer AG, Pipeline Products by Therapy Area 14
Bayer AG, Pipeline Products by Development Phase 15
Bayer AG - History 23
Bayer AG - Locations And Subsidiaries 37
Head Office 37
Other Locations and Subsidiaries 37
Joint Venture 47
Section 2 - Company Analysis 48
Bayer AG - Business Description 48
Bayer AG - Corporate Strategy 50
Bayer AG - SWOT Analysis 51
SWOT Analysis - Overview 51
Bayer AG - Strengths 51
Strength - Lead Segment - HealthCare Products 51
Strength - Strong In-house Research Expertise 51
Strength - Best-Selling Pharmaceuticals Products 51
Bayer AG - Weaknesses 52
Weakness - Product Side Effects 52
Bayer AG - Opportunities 53
Opportunity - Strategic Acquisitions 53
Opportunity - Product Launches and Approvals 53
Opportunity - Increasing Need: Improved Agricultural Production 53
Bayer AG - Threats 54
Threat - Growing Parallel Trade 54
Threat - Government Regulations 54
Threat - Increasing Competitive Pressures 54
Bayer AG - Key Competitors 55
Section 3 - Company Financial Ratios 56
Financial Ratios - Capital Market Ratios 56
Financial Ratios - Annual Ratios 57
Performance Chart 59
Financial Performance 59
Financial Ratios - Interim Ratios 60
Financial Ratios - Ratio Charts 61
Section 4 - Company's Lifesciences, Power Financial Deals and Alliances 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 63
Bayer AG, Petrochemicals, Deals By Year, 2010 to YTD 2016 64
Bayer AG, Petrochemicals, Deals By Type, 2010 to YTD 2016 65
Bayer AG, Recent Deals Summary 66
Section 5 - Company's Recent Developments 67
Mar 23, 2016: Dr. Michael Preuss to be new head of Communications at Bayer 67
Feb 25, 2016: Another record year for Bayer 68
Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG 72
Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG 73
Feb 09, 2016: Bayer Continues to Grow its Open Innovation Activities 74
Dec 17, 2015: American Association for Cancer Research and Bayer Form Partnership on Grant Opportunities in Cancer Research 76
Nov 04, 2015: Bayer leads the way in climate protection and water management 77
Oct 29, 2015: Bayer posts strong earnings growth 78
Oct 01, 2015: Bayer Appoints Habib Dable to Lead U.S. Pharmaceuticals Business 81
Sep 18, 2015: Bayer aligns organization with Life Science businesses 82
Section 6 - Appendix 84
Methodology 84
Ratio Definitions 84
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Tables
Bayer AG, Key Facts 6
Bayer AG, Key Employees 7
Bayer AG, Key Employee Biographies 10
Bayer AG, Major Products and Services 11
Bayer AG, Number of Pipeline Products by Therapy Area 14
Bayer AG, Number of Pipeline Products by Development Stage 15
Bayer AG, Pipeline Products By Therapy Area and Development Phase 16
Bayer AG, History 23
Bayer AG, Subsidiaries 37
Bayer AG, Joint Venture 47
Bayer AG, Key Competitors 55
Bayer AG, Ratios based on current share price 56
Bayer AG, Annual Ratios 57
Bayer AG, Interim Ratios 60
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 62
Bayer AG, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 63
Bayer AG, Petrochemicals, Deals By Year, 2010 to YTD 2016 64
Bayer AG, Petrochemicals, Deals By Type, 2010 to YTD 2016 65
Bayer AG, Recent Deals Summary 66
Currency Codes 84
Capital Market Ratios 84
Equity Ratios 85
Profitability Ratios 85
Cost Ratios 86
Liquidity Ratios 86
Leverage Ratios 87
Efficiency Ratios 87

List of Figures
Bayer AG, Pipeline Products by Therapy Area 14
Bayer AG, Pipeline Products by Development Phase 15
Bayer AG, Performance Chart (2011 - 2015) 59
Bayer AG, Ratio Charts 61
Bayer AG, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 62
Bayer AG, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 63
Bayer AG, Petrochemicals, Deals By Year, 2010 to YTD 2016 64
Bayer AG, Petrochemicals, Deals by Type, 2010 to YTD 2016 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.